Blocking of the placental immune-modulatory ferritin activates Th1 type cytokines and effects placenta development, fetal growth and the pregnancy outcome

Human Reproduction

Volumn 19, Issue 3, 2004, Pages 715-722

  Nahum, R ^a   Brenner, O ^b   Zahalka, M A ^a   Traub, L ^a   Quintana, F ^b   Moroz, C ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Abortion; Cytokines placenta; PLIF; Pregnacy; Resorption

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; FERRITIN; FERRITIN ANTIBODY; IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; PLACENTAL IMMUNOMODULATORY FERRITIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COITUS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DELIVERY; EMBRYO GROWTH; EMBRYO RESORPTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; FETUS GROWTH; GENE EXPRESSION; GESTATIONAL AGE; HISTOPATHOLOGY; HYPOPLASIA; IMMUNOMODULATION; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; INTRAUTERINE GROWTH RETARDATION; MATERNAL BLOOD; MATING; MOLECULAR CLONING; MONONUCLEAR CELL; NONHUMAN; PASSIVE IMMUNIZATION; PLACENTA; PLACENTA DEVELOPMENT; PREGNANCY; PROTEIN BLOOD LEVEL; PROTEIN DOMAIN; REPRODUCTION; SPLEEN CELL; TH1 CELL; TH2 CELL; VACCINATION;

ESCHERICHIA COLI;

EID: 1542711637     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deh099     Document Type: Article

References (31)

1. Abe N, Katamura K and Shintakci N (1997) Prostaglandin E2 and IL4 provide naïve, CD4+ T cells with distinct inhibitory signals for priming of IFNγ production. Cell Immunol 181,86-92.
2. Atiken RJ (2002) Immunocontraceptive vaccines for human use. J Reprod Immunol 57,273-287.
3. Bar J, Maymon R, Hod M, Manor Y and Moroz C (1998) Low serum placental isoferritin in pregnant women at risk of developing pre-eclampsia. Hypertens Pregn 17,315-321.
4. Chaouat G, Cayol V, Mairovitz V and Dubanchet S (1999) Localization of the Th2 cytokines IL-3, IL-4, IL-10 at the feto-maternal interface during human and murine pregnancy and lack of requirement for Fas/Fas ligand interaction for a successful allogeneic pregnancy. Am J Reprod Immunol, 42,1-13.
5. Clark DA, Arck PC and Schaouat G (1999a) Why did your mother reject you? Immunogenetic determinants of the response to environmental selective pressure expressed at the uterine level. Am J Reprod Immunol 41,5.
6. Clark DA, Ding JW, Chaouat G, Coulman CB, August C and Levy GA (1999b) The emerging role of immunoregulation of fibrinogen related procoagulant Fg1 12 in the success or spontaneous abortion of early pregnancy in mice and humans. Am J Reprod Immunol 42,37-43.
7. Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P and Moreau T (1998) The pregnancy in Multiple Sclerosis Group. Rate of pregnancy-related elapse in multiple sclerosis. N Engl J Med 339,285-291.
8. Dealtry GB, O'Farrell MK and Fernandez N (2000) The Th2 cytokine environment of the placenta. Int Arch Allergy Immunol 123,107-119.
9. Fisch B, Manor Y, Ovadia J and Moroz C (1996) Placental isoferritin as a marker of early abortions in pregnancies induced by in vitro fertilization. Placenta 17,247-251.
10. Georgiades P, Ferguson-Smith AC and Burton GJ (2002) Comparative developmental anatomy of the murine and human definitive placentae. Placenta 23,3.
11. Gilman-Sachs A, Thaker P, Beaman KD, Beer AE and Kwak-Kim J (2002) Expression of intracellular Th1 and Th2 cytokines in women with recurrent spontaneous abortion, implantation failure after IVF/ET or normal pregnancy. Am J Reprod Immunol 48,77.
12. Hill JA and Choi BC (2000) Immunodystrophism: Evidence for a novel alloimmune hypothesis for recurrent pregnancy loss involving Th1-type immunity to trophoblast. Semin Reprod Med 18,401-405.
13. Maymon R and Moroz Ch (1996) Placental isoferritin: A new biomarker from conception to delivery. Br J Obstet Gynecol 103,301-305.
14. Maymon R, Bahari C and Moroz Ch (1989) Placental isoferritin measured by a specific monoclonal antibody as a new predictive marker for premature contraction outcome. Obstet Gynecol 74,1-3.
15. Maymon R, Zitzer P, Manor Y, Bukovsky I and Moroz Ch (1995) Placental isoferritin patterns during normal first trimester and tubal gestation. Hum Reprod 10,101-103.
16. Maymon R, Jauniaux E, Greenwold N and Moroz Ch (2000) Localization of p43 placental isoferritin in human feto-maternal tissue interface. Am J Obstet Gynecol, 182,670-674.
17. Mellor AL and Munn DH (2000) Immunology at the maternal-fetal interface: Lessons for T cell tolerance and suppression. Annu Rev Immunol 18,367-391.
18. Moroz Ch and Bessler H (1989) Ferritin as a marker in malignancy. In de Sousa M and Brock J (eds) Iron, The Lymphomyeloid System, Inflammation and Malignancy. Wiley, NewYork.
19. Moroz Ch, Kupfer B, Twig Sh and Parhami-Seren B (1985) Preparation and characterization of monoclonal antibodies specific to placenta ferritin. Clin Chem Acta, 148,111-118.
20. Moroz Ch, Traub L, Maymon R and Zahalka M (2002) PLIF- a novel human ferritin subunit from placenta with immunosuppressive activity. J Biol Chem 277,12901-12905.
21. Morton H (1998) Early pregnancy factor: An extracellular chaperonin 10 homologue. Immunol Cell Biol 76,483-496.
22. Østensen M and Husby G (1983) A prospective clinical study of the effect of pregnancy on rheumatoid arthritis and ankylosing spondylitis. Arthrit Rheum 26,1155-1159.
23. Piccini MP, Gindizi MG, Biagiotti R, Beloni L, Gianarini L, Sampogriardo S, Parronchi P, Manetti R, Annunziato F, Livi C, Romagnani S and Magi E (1995) Progesterone favours the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol 155,128-133.
24. Quintana FJ, Rotem A, Carmi P and Cohen IR (2000) Vaccination with empty plasmid DNA or CpG oligonucleotide inhibits diabetes in nonobese diabetic mice: Modulation of spontaneous 60-kDa heat shock protein autoimmunity. J Immunol 165,6148.
25. Raghupathy R (1997) Th1-type immunity is incompatible with successful pregnancy. Immunol Today 18,479-482.
26. Redline RW and Patterson P (1995) Pre-eclampsia is associated with excess of proliferative immature intermediate trophobalst. Hum Pathol 26,596.
27. Rosen AC, Hafner E, Auerbach L, Rosen HR, Schuchter K, Huber K, Ausch Ch and Moroz Ch (1996) Placental isoferritin in pregnancies with small-for-gestational age fetuses. Prenat Diagn 16,641-646.
28. Szekeres-Barto J and Wegmann TG (1996) A progesterone-dependent immunomodulatory protein alerts the Th1/Th2 balance. J Reprod Immunol 31,81-95.
29. Wegmann TG, Lin H, Guilbert L and Mosmann TR (1993) Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today 14,353-356.
30. Weinberger A, Halpern M, Zahalka MA, Quintana F, Traub L and Moroz C (2003) PLIF-a novel immunoregulator suppressed experimental arthritis. Arthrit Rheum 48,846-853.
31. Zahalka MA, Barak V, Traub L and Moroz C (2003) The bioactive domain of PLIF is a direct inducer of IL-10 production in monocytes; a calcium/calmodulin-p38 MAP kinase dependent pathway. FASEB J 17,955-957.